Using real-world data, Mass General Brigham researchers reveal how the combination of two blood cancer medications can improve outcomes for patients...
Vous n'êtes pas connecté
- ONCOLOGYNEWS.COM.AU - A La Une - 15/07/2024 21:35
Stem cell-derived therapy shows promise against treatment-resistant liver cancer
Researchers at University of California San Diego, USA, have found that the most common form of liver cancer — one with a high mortality rate — can be better targeted and treated using an innovative new stem cell-derived therapy, according to a recently published study in Cell Stem Cell. The treatment, not yet studied in [...]
Articles similaires
Study demonstrates drug combination is well tolerated, safe and effective for patients with aggressive blood cancer
oncologynews.com.au - 01/Jul 15:38
Using real-world data, Mass General Brigham researchers reveal how the combination of two blood cancer medications can improve outcomes for patients...
Study unveils powerful strategy to rejuvenate effectiveness of CAR T cell therapy against glioblastoma
news.medical.net - 03/Jul 06:19
A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and Luigi Naldini, has...
Scientists find how to reverse type 1 diabetes
knowridge.com - 02/Jul 10:50
A groundbreaking clinical trial led by researchers from the University of Toronto has shown that a new stem cell–derived therapy called zimislecel...
Understanding how a key protein helps aggressive blood cancer grow, paving the way for targeted therapies
oncologynews.com.au - 01/Jul 15:19
Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Understanding how a key protein helps aggressive blood cancer grow, paving the way for targeted therapies
oncologynews.com.au - 01/Jul 15:19
Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Immunotherapy–targeted therapy combinations show promise in rare kidney cancer subtypes
oncologynews.com.au - 04/Jul 12:58
New Meta-analysis Backs Efficacy in nccRCC A new systematic review and meta-analysis have reinforced the growing evidence base for immunotherapy-based...
Breast Cancer Risk in Younger Women May Be Influenced by Hormone Therapy
drugs.com - 30/Jun 02:07
June 30, 2025 -- Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer...
HER2-mutated NSCLC in Brazil shows diverse genetic patterns and treatment gaps
oncologynews.com.au - 06/Jul 21:13
A new research paper was published in Volume 16 of Oncotarget, titled “Molecular landscape of HER2-mutated non-small cell lung cancer in...
Parkinson’s drug shows promise for hard-to-treat depression
knowridge.com - 04/Jul 10:12
A drug commonly used for Parkinson’s disease, called pramipexole, has shown strong results in helping people with depression that hasn’t improved...
Les derniers communiqués
-
Aucun élément